Table 1.
Patient, tumor, and treatment characteristics
| Characteristic | Prone n = 8 (%) |
Supine n = 9 (%) |
|---|---|---|
| Median age, yrs. (range) | 65 (40–86) | 78 (47–86) |
| Sex | ||
| M F |
4 (50) 4 (50) |
5 (56) 4 (44) |
| Tumour statusa | ||
| T1–2 T3 T4 |
0 (0) 6 (75) 2 (25) |
0 (0) 8 (89) 1 (11) |
| Node status | ||
| Positive Negative |
4 (50) 4 (50) |
6 (67) 3 (33) |
| Radiation Preoperative Definitive RT dose |
7 (88) 1 (12) 50.4 Gy in 28 (n = 7) 40 Gy in 15 (n = 1) |
9 (100) 0 (0) 50.4 Gy in 28 (n = 8) 25 Gy in 5 (n = 1) |
| Concurrent chemotherapy | ||
| Capecitabine None |
7 1 |
8 1 |
aClinical stage based on diagnostic MRI